These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11230881)

  • 1. Effects of nicotine pretreatment on dopaminergic and behavioral responses to conditioned fear stress in rats: dissociation of biochemical and behavioral effects.
    George TP; Picciotto MR; Verrico CD; Roth RH
    Biol Psychiatry; 2001 Feb; 49(3):300-6. PubMed ID: 11230881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress.
    George TP; Verrico CD; Roth RH
    Brain Res; 1998 Aug; 801(1-2):36-49. PubMed ID: 9729261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat.
    Goldstein LE; Rasmusson AM; Bunney BS; Roth RH
    J Neurosci; 1994 Aug; 14(8):4937-50. PubMed ID: 8046462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms.
    George TP; Verrico CD; Xu L; Roth RH
    Neuropsychopharmacology; 2000 Jul; 23(1):79-88. PubMed ID: 10869888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (S)-(-)-HA-966, a gamma-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism and behavioral correlates of restraint stress, conditioned fear and cocaine sensitization.
    Morrow BA; Lee EJ; Taylor JR; Elsworth JD; Nye HE; Roth RH
    J Pharmacol Exp Ther; 1997 Nov; 283(2):712-21. PubMed ID: 9353390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine enhances behavioral and mesocorticolimbic dopaminergic responses to aversive conditioning.
    Morrow BA; Elsworth JD; Roth RH
    Synapse; 1996 Feb; 22(2):100-5. PubMed ID: 8787125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine-induced behavioral sensitization is associated with extracellular dopamine release and expression of c-Fos in the striatum and nucleus accumbens of the rat.
    Shim I; Javaid JI; Wirtshafter D; Jang SY; Shin KH; Lee HJ; Chung YC; Chun BG
    Behav Brain Res; 2001 Jun; 121(1-2):137-47. PubMed ID: 11275291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of environmental conditioning on the development of nicotine sensitization: behavioral and neurochemical analysis.
    Reid MS; Ho LB; Berger SP
    Psychopharmacology (Berl); 1996 Aug; 126(4):301-10. PubMed ID: 8878346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and neurochemical components of nicotine sensitization following 15-day pretreatment: studies on contextual conditioning.
    Reid MS; Ho LB; Berger SP
    Behav Pharmacol; 1998 Mar; 9(2):137-48. PubMed ID: 10065933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex.
    Bassareo V; De Luca MA; Di Chiara G
    Psychopharmacology (Berl); 2007 Apr; 191(3):689-703. PubMed ID: 17072592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic alpha-2 agonists have anxiolytic-like actions on stress-related behavior and mesoprefrontal dopamine biochemistry.
    Morrow BA; George TP; Roth RH
    Brain Res; 2004 Nov; 1027(1-2):173-8. PubMed ID: 15494168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine.
    Cadoni C; Di Chiara G
    Eur J Pharmacol; 2000 Jan; 387(3):R23-5. PubMed ID: 10650185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization.
    George TP; Verrico CD; Picciotto MR; Roth RH
    J Pharmacol Exp Ther; 2000 Oct; 295(1):58-66. PubMed ID: 10991961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats.
    Palmatier MI; Bevins RA
    Neuropsychobiology; 2002; 45(2):87-94. PubMed ID: 11893865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of (+)-SKF-10,047-sensitive sub-population of sigma 1 receptors in amelioration of conditioned fear stress in rats: association with mesolimbic dopaminergic systems.
    Kamei H; Noda Y; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1997 Jan; 319(2-3):165-72. PubMed ID: 9042587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat.
    Morrow BA; Elsworth JD; Rasmusson AM; Roth RH
    Neuroscience; 1999; 92(2):553-64. PubMed ID: 10408604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and behavioral anxiolytic-like effects of R(+)HA-966 at the level of the ventral tegmental area in rats.
    Morrow BA; Elsworth JD; Zito C; Roth RH
    Psychopharmacology (Berl); 1999 Apr; 143(3):227-34. PubMed ID: 10353424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of blockade of dopamine D2 receptors on extracellular citrulline levels in the nucleus accumbens during performance of a conditioned reflex fear response.
    Saul'skaya NB; Fofonova NV; Sudorgina PV
    Neurosci Behav Physiol; 2010 Jan; 40(1):47-54. PubMed ID: 20012493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predator odor, TMT, displays a unique, stress-like pattern of dopaminergic and endocrinological activation in the rat.
    Morrow BA; Redmond AJ; Roth RH; Elsworth JD
    Brain Res; 2000 May; 864(1):146-51. PubMed ID: 10793199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of withdrawal from an escalating dose of amphetamine on conditioned fear and dopamine response in the medial prefrontal cortex.
    Peleg-Raibstein D; Feldon J
    Behav Brain Res; 2008 Jan; 186(1):12-22. PubMed ID: 17884189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.